DGCI accepts proposal to study mixing of two different COVID vaccines
The apex medical body has stated that such a mixed regimen will help to ‘overcome the challenges of the shortfall of particular vaccines and remove hesitancy’.
A new the Indian Council of Medical Research (ICMR) study has shown mixing Covishield and Covaxin, the two main vaccines against Covid-19 to be safe and provide better immunity.
The research body has stated that such mixing vaccines will help to ‘overcome the challenges of the shortfall of particular vaccines and remove hesitancy’.
Permission has been granted for research study at CMC Vellore on mixing of vaccine doses, news agency ANI quoted Dr VK Paul, Niti Aayog, as saying.
Worldwide, studies are underway to understand if mixing of two different vaccines can yield better results than two doses of the same vaccine.
However, scientists have warned that the mixing should not be done randomly, but rather based on multiple issues.
The Central Drugs Standard Control Organisation’s (CDSCO) Subjects Experts Committee (SEC) on July 29 had recommended Christian Medical College (CMC) in Vellore in the southern state for a study to be conducted in this regard.
The proposed trial will now see 300 volunteers being administered a dose each of Covaxin and Covishield.